iRhythm Technologies Inc
IRTC179.430USD
-9.820-5.19%
Close 01/09, 16:00（ET）Quotes delayed by 15 min
5.78BMarket Cap
LossP/E TTM
More Details of iRhythm Technologies Inc Company
iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry (MCT) monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
iRhythm Technologies Inc Info
Ticker SymbolIRTC
Company nameiRhythm Technologies Inc
IPO dateOct 20, 2016
CEOBlackford (Quentin S)
Number of employees2000
Security typeOrdinary Share
Fiscal year-endOct 20
Address699 8th Street
CitySAN FRANCISCO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94103
Phone14156325700
Websitehttps://www.irhythmtech.com/
Ticker SymbolIRTC
IPO dateOct 20, 2016
CEOBlackford (Quentin S)
Company Executives of iRhythm Technologies Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Quentin S. Blackford
Mr. Quentin S. Blackford
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
63.30K
-14059.00%
Ms. Sumi Shrishrimal
Ms. Sumi Shrishrimal
Executive Vice President, Chief Risk Officer
Executive Vice President, Chief Risk Officer
33.85K
+73.00%
Mr. Abhijit Y. (Abhi) Talwalkar
Mr. Abhijit Y. (Abhi) Talwalkar
Independent Chairman of the Board
Independent Chairman of the Board
18.46K
--
Mr. Mervin Smith
Mr. Mervin Smith
Executive Vice President - Business Operations
Executive Vice President - Business Operations
15.84K
-616.00%
Dr. Minang (Mintu) Turakhia, M.D.
Dr. Minang (Mintu) Turakhia, M.D.
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
12.81K
+250.00%
Dr. Ralph Snyderman, M.D.
Dr. Ralph Snyderman, M.D.
Independent Director
Independent Director
11.45K
+1358.00%
Mr. Bruce G. Bodaken
Mr. Bruce G. Bodaken
Independent Director
Independent Director
10.80K
+1358.00%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
7.73K
+1358.00%
Mr. Daniel G. (Dan) Wilson
Mr. Daniel G. (Dan) Wilson
Chief Financial Officer
Chief Financial Officer
3.96K
-8000.00%
Dr. Cathleen Noel Bairey Merz, M.D.
Dr. Cathleen Noel Bairey Merz, M.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Quentin S. Blackford
Mr. Quentin S. Blackford
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
63.30K
-14059.00%
Ms. Sumi Shrishrimal
Ms. Sumi Shrishrimal
Executive Vice President, Chief Risk Officer
Executive Vice President, Chief Risk Officer
33.85K
+73.00%
Mr. Abhijit Y. (Abhi) Talwalkar
Mr. Abhijit Y. (Abhi) Talwalkar
Independent Chairman of the Board
Independent Chairman of the Board
18.46K
--
Mr. Mervin Smith
Mr. Mervin Smith
Executive Vice President - Business Operations
Executive Vice President - Business Operations
15.84K
-616.00%
Dr. Minang (Mintu) Turakhia, M.D.
Dr. Minang (Mintu) Turakhia, M.D.
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
12.81K
+250.00%
Dr. Ralph Snyderman, M.D.
Dr. Ralph Snyderman, M.D.
Independent Director
Independent Director
11.45K
+1358.00%
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Commercial Payors
99.01M
51.33%
Contracted third-party payors
99.01M
51.33%
Centers for Medicare & Medicaid
47.56M
24.66%
Healthcare Institutions
32.79M
17.00%
Non-contracted third-party payors
13.52M
7.01%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Commercial Payors
99.01M
51.33%
Contracted third-party payors
99.01M
51.33%
Centers for Medicare & Medicaid
47.56M
24.66%
Healthcare Institutions
32.79M
17.00%
Non-contracted third-party payors
13.52M
7.01%
Shareholding Stats
Updated: Sun, Nov 30
Updated: Sun, Nov 30
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
10.03%
Artisan Partners Limited Partnership
7.97%
BlackRock Institutional Trust Company, N.A.
7.35%
Sands Capital Management, LLC
6.94%
Capital Research Global Investors
3.67%
Other
64.04%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
10.03%
Artisan Partners Limited Partnership
7.97%
BlackRock Institutional Trust Company, N.A.
7.35%
Sands Capital Management, LLC
6.94%
Capital Research Global Investors
3.67%
Other
64.04%
Shareholder Types
Shareholders
Proportion
Investment Advisor
63.25%
Investment Advisor/Hedge Fund
28.42%
Hedge Fund
10.19%
Research Firm
5.20%
Family Office
1.35%
Pension Fund
0.97%
Individual Investor
0.86%
Sovereign Wealth Fund
0.71%
Bank and Trust
0.54%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
633
35.16M
109.12%
-4.05M
2025Q3
609
36.08M
112.00%
-5.27M
2025Q2
586
36.46M
113.50%
-2.59M
2025Q1
586
36.68M
114.94%
-2.13M
2024Q4
571
35.12M
111.82%
-4.41M
2024Q3
584
35.86M
114.62%
-4.91M
2024Q2
581
36.60M
117.28%
-2.20M
2024Q1
578
35.68M
114.75%
-1.24M
2023Q4
542
34.05M
110.03%
-1.99M
2023Q3
543
34.13M
111.64%
-2.86M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
3.23M
10.03%
+4.15K
+0.13%
Sep 30, 2025
Artisan Partners Limited Partnership
2.57M
7.97%
-173.33K
-6.32%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
2.37M
7.35%
+37.79K
+1.62%
Sep 30, 2025
Sands Capital Management, LLC
2.24M
6.94%
-679.42K
-23.30%
Sep 30, 2025
Capital Research Global Investors
1.18M
3.67%
-323.13K
-21.44%
Sep 30, 2025
State Street Investment Management (US)
847.88K
2.63%
-20.65K
-2.38%
Sep 30, 2025
Geode Capital Management, L.L.C.
790.10K
2.45%
+22.77K
+2.97%
Sep 30, 2025
William Blair & Company, L.L.C. (Research)
740.72K
2.3%
+1.39K
+0.19%
Sep 30, 2025
Eventide Asset Management, LLC
691.51K
2.15%
-61.00
-0.01%
Sep 30, 2025
Fuller & Thaler Asset Management Inc.
595.25K
1.85%
+8.77K
+1.50%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Global X HealthTech ETF
4.17%
First Trust Nasdaq Lux Digi Health Solutions ETF
2.08%
State Street SPDR S&P Health Care Equipment ETF
1.84%
Invesco Dorsey Wright Healthcare Momentum ETF
1.73%
Langar Global HealthTech ETF
1.72%
ROBO Global Healthcare Technology & Innovation ETF
1.66%
First Trust Multi-Manager Small Cap Opportunities ETF
1.55%
Inspire Fidelis Multi Factor ETF
1.09%
Harbor Health Care ETF
0.91%
Goldman Sachs Future Health Care Equity ETF
0.86%
View more
Global X HealthTech ETF
Proportion4.17%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion2.08%
State Street SPDR S&P Health Care Equipment ETF
Proportion1.84%
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion1.73%
Langar Global HealthTech ETF
Proportion1.72%
ROBO Global Healthcare Technology & Innovation ETF
Proportion1.66%
First Trust Multi-Manager Small Cap Opportunities ETF
Proportion1.55%
Inspire Fidelis Multi Factor ETF
Proportion1.09%
Harbor Health Care ETF
Proportion0.91%
Goldman Sachs Future Health Care Equity ETF
Proportion0.86%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of iRhythm Technologies Inc?
The top five shareholders of iRhythm Technologies Inc are:
The Vanguard Group, Inc. holds 3.23M shares, accounting for 10.03% of the total shares.
Artisan Partners Limited Partnership holds 2.57M shares, accounting for 7.97% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 2.37M shares, accounting for 7.35% of the total shares.
Sands Capital Management, LLC holds 2.24M shares, accounting for 6.94% of the total shares.
Capital Research Global Investors holds 1.18M shares, accounting for 3.67% of the total shares.
The Vanguard Group, Inc. holds 3.23M shares, accounting for 10.03% of the total shares.
Artisan Partners Limited Partnership holds 2.57M shares, accounting for 7.97% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 2.37M shares, accounting for 7.35% of the total shares.
Sands Capital Management, LLC holds 2.24M shares, accounting for 6.94% of the total shares.
Capital Research Global Investors holds 1.18M shares, accounting for 3.67% of the total shares.
What are the top three shareholder types of iRhythm Technologies Inc?
The top three shareholder types of iRhythm Technologies Inc are:
The Vanguard Group, Inc.
Artisan Partners Limited Partnership
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Artisan Partners Limited Partnership
BlackRock Institutional Trust Company, N.A.
How many institutions hold shares of iRhythm Technologies Inc (IRTC)?
As of 2025Q4, 633 institutions hold shares of iRhythm Technologies Inc, with a combined market value of approximately 35.16M, accounting for 109.12% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -2.88%.
What is the biggest source of revenue for iRhythm Technologies Inc?
In FY2025Q3, the Commercial Payors business generated the highest revenue for iRhythm Technologies Inc, amounting to 99.01M and accounting for 51.33% of total revenue.
